<SEC-DOCUMENT>0001104659-22-118759.txt : 20221114
<SEC-HEADER>0001104659-22-118759.hdr.sgml : 20221114
<ACCEPTANCE-DATETIME>20221114172332
ACCESSION NUMBER:		0001104659-22-118759
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20221114
DATE AS OF CHANGE:		20221114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AYTU BIOPHARMA, INC
		CENTRAL INDEX KEY:			0001385818
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				470883144
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-239010
		FILM NUMBER:		221387911

	BUSINESS ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 206
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		(720) 437-6580

	MAIL ADDRESS:	
		STREET 1:		373 INVERNESS PARKWAY
		STREET 2:		SUITE 206
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AYTU BIOSCIENCE, INC
		DATE OF NAME CHANGE:	20150609

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AYTU BIOSCIENCE, INC.
		DATE OF NAME CHANGE:	20150609

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Rosewind CORP
		DATE OF NAME CHANGE:	20070110
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>tm2230448d1_424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed Pursuant to Rule 424(b)(5)<BR>
Registration No. 333-239010</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>AMENDMENT NO. 1 DATED NOVEMBER 14, 2022
<BR>
to Prospectus Supplement dated June 4, 2021 <BR>
(to Prospectus dated June 17, 2020)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><B><IMG SRC="tm2230448d1_424b5img001.jpg" ALT="">&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Up to $4,300,000<BR>
Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Amendment No. 1 to Prospectus Supplement (this "Amendment") amends our prospectus supplement dated June 4, 2021 (the "Prospectus
Supplement").</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We previously entered into a Controlled
Equity Offering<SUP>SM</SUP> Sales Agreement, or Sales Agreement, with Cantor Fitzgerald &amp; Co., or Cantor, pursuant to which we
may offer and sell shares of our common stock from time to time through Cantor, acting as sales agent, having an aggregate offering
price of up to $30,000,000. As of November 14, 2022, we have sold $5,233,324 of our common stock under the Sales Agreement pursuant
to our prospectus dated June 17, 2020, as supplemented by the Prospectus Supplement dated June 4, 2021 (together, the
 &#8220;Prospectus&#8221;), which leaves $24,766,676 of common stock available under the Prospectus. This Amendment
should be read in conjunction with the Prospectus, and is qualified by reference thereto, except to the extent that the information
herein amends or supersedes the information contained in the Prospectus. This Amendment is not complete without, and may
only be delivered or utilized in connection with, the Prospectus, and any future amendments or supplements thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are now subject to General Instruction I.B.6
of Form S-3, which limits the amounts that we may sell under the registration statement of which this Amendment and the Prospectus
form a part. The aggregate market value of our common stock held by non-affiliates pursuant to General Instruction I.B.6 of Form S-3 is
approximately $13.0 million, which was calculated based on approximately 59.3 million shares of our outstanding common stock held by non-affiliates
on November 3, 2022 at a price of $0.22 per share, the price of our common stock on September 15, 2022. During the 12 calendar months
prior to, and including, the date of this Amendment, we have not sold any securities pursuant to General Instruction I.B.6
of Form S-3. As a result of the limitations of General Instruction I.B.6, and in accordance with the terms of the Sales Agreement, we
are registering the offer and sale of shares of our common stock having an aggregate offering price of up to $4.3 million from time to
time through Cantor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our common stock trades on the Nasdaq Capital
Market under the symbol &#8220;AYTU&#8221;. On November 10, 2022, the last reported sale price for our common stock on the Nasdaq Capital
Market was $0.16 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investing in our common stock involves risks.
You should read this Amendment and the accompanying Prospectus, as well as the risk factors referred to on page S-8 of the
prospectus supplement dated June 4, 2021 under the caption &#8220;Risk Factors&#8221; and those contained or described in the documents
incorporated by reference in this Amendment and the accompanying Prospectus, before you invest.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities, or determined if this Amendment and the
accompanying Prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="tm2230448d1_424b5img002.jpg" ALT=""><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The date of this Amendment No. 1 to
Prospectus Supplement is November 14, 2022</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2230448d1_424b5img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2230448d1_424b5img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !0 0T# 2(  A$! Q$!_\0
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M5RO^V."?H>OXT".MJK?WL.GV,]Y<N$AA0N['L!5C<3VKQKXX>+?L]I'X<MI
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MX[640Q0EL #&=W%3-X7BDMYA/>337,[*TD[ 9.WH,=JGOM%::\-Y97<EG<.
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M-S#G@CK[U-I]U=7WBJWNY2Z07$+F"$C&U.Q;GJ:WK725M[Z2[DF:622)8W#
M8('>FWFD+=WBW*3O!(D#PH4'W=W?ZB@#E;W6XO[5DU@7RA+280K;A_OQYPQQ
M^M=[$ZR('7!4@$$=ZH0:)I\-DEK]FC90FW<R#)_&K-A:K8V4-JK,RQ*%#-U-
$ '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm2230448d1_424b5img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2230448d1_424b5img002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  B (D# 2(  A$! Q$!_\0
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G****104444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
